Several leading organizations worldwide focus on the production of complex drug APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Acetate. These substances present significant hurdles in process development due to their molecular intricacy. The suppliers of these APIs often employ specialized methods and adhere to strict compliance protocol